Wilbanks Smith & Thomas Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.12M | Sell |
8,735
-49
| -0.6% | -$6.29K | 0.03% | 217 |
|
|
2023
Q4 | $909K | Buy |
8,784
+71
| +0.8% | +$7.35K | 0.03% | 241 |
|
|
2023
Q3 | $792K | Buy |
8,713
+5,731
| +192% | +$521K | 0.03% | 245 |
|
|
2023
Q2 | $241K | Sell |
2,982
-652
| -18% | -$52.8K | 0.01% | 457 |
|
|
2023
Q1 | $289K | Buy |
3,634
+54
| +2% | +$4.3K | 0.01% | 412 |
|
|
2022
Q4 | $242K | Buy |
+3,580
| New | +$242K | 0.01% | 428 |
|
|
2018
Q4 | – | Sell |
-2,752
| Closed | -$65K | – | 994 |
|
|
2018
Q3 | $65K | Buy |
+2,752
| New | +$65K | ﹤0.01% | 626 |
|